Clinical Trial Update: Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers [Phase 3]

View source ↗

Summary

Phase 3 trial updating aprepitant for chemotherapy-induced nausea and vomiting in Chinese patients with advanced non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Carcinoma, Non-small Cell Lung | Phase 3 | Status: COMPLETED